816 / 1835
Progression-Free Survival
Median PFS (95% CI): NA (18.6–NA)
Time, Months
Proportion of Patients Without Progression
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0
3
6
9
12
15
21
27
18
No. Patients at Risk
24
23
20
13
12
11
8
1
0
5
11
•
Median follow-up: 101 wks